PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97923896 |
Filing Date: 05/06/2023 |
Input Field |
Entered |
SERIAL NUMBER | 97923896 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\979\238\97923896\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | Elevidys |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of three alternately-shaded semicircles increasing in size to an oval center and three alternately-shaded semicircles decreasing in size on the other side of the oval center and followed by 'Elevidys.' The color gray is intended to show shading or contrast only. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 652 x 257 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Sarepta Therapeutics, Inc. |
*MAILING ADDRESS | 215 First Street |
*CITY | Cambridge |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02142 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
ACTIVE PRIOR REGISTRATION(S) | The applicant claims ownership of active prior U.S. Registration Number(s) 7037471. |
ATTORNEY INFORMATION | |
NAME | Maury M. Tepper, III |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Tepper & Eyster, PLLC |
STREET | 3724 Benson Drive |
CITY | Raleigh |
STATE | North Carolina |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 27609 |
PHONE | 919-861-8903 |
FAX | 919-861-8913 |
EMAIL ADDRESS | mtepper@teiplaw.com |
OTHER APPOINTED ATTORNEY | Kathryn M. Eyster |
CORRESPONDENCE INFORMATION | |
NAME | Maury M. Tepper, III |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | mtepper@teiplaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | tmorris@teiplaw.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Maury M. Tepper, III/ |
SIGNATORY'S NAME | Maury M. Tepper, III |
SIGNATORY'S POSITION | Attorney of Record, NC Bar member |
SIGNATORY'S PHONE NUMBER | 919-861-8903 |
DATE SIGNED | 05/06/2023 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97923896 |
Filing Date: 05/06/2023 |
The applicant's current Correspondence Information: |
Maury M. Tepper, III |
PRIMARY EMAIL FOR CORRESPONDENCE: mtepper@teiplaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmorris@teiplaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|